基础化工行业周报：万华首套年产25万吨LDPE装置投产，欧盟对华钛白粉反倾销终裁落地

Investment Rating - The report maintains a rating of "Outperform" for the chemical industry, indicating a positive outlook for the sector [5]. Core Insights - The chemical sector has shown strong performance, with the CITIC Basic Chemical Index rising by 5.01% this week, outperforming major indices like the Shanghai Composite and the ChiNext [14][16]. - Key investment themes include the competitiveness of domestic tire manufacturers, the potential recovery in consumer electronics, and the resilience of certain cyclical industries [4][9]. Summary by Sections Industry Performance - The overall market performance for the chemical sector this week includes a 2.31% increase in the Shanghai Composite Index and a 4.66% increase in the ChiNext Index [14]. - The top-performing sub-industries include phosphate fertilizers and phosphate chemicals (7.22%), polyester (7.06%), and membrane materials (6.89%) [16]. Major Industry Developments - Wanhua Chemical successfully launched its first 250,000 tons/year LDPE plant, marking a significant milestone in production capabilities [3]. - The EU has finalized anti-dumping duties on titanium dioxide imports from China, impacting several companies in the sector [3]. Investment Themes - Investment Theme 1: Domestic tire manufacturers are becoming increasingly competitive, with companies like Sailun Tire and Linglong Tire recommended for attention [4]. - Investment Theme 2: The consumer electronics sector is expected to gradually recover, benefiting upstream material companies such as Dongcai Technology and Stik [4]. - Investment Theme 3: The phosphate chemical industry is tightening supply due to environmental regulations, making companies like Yuntianhua and Chuanheng shares attractive [9]. - Investment Theme 4: The fluorochemical sector is poised for recovery as production quotas for second-generation refrigerants are reduced, with companies like Jushi Resources highlighted [9]. - Investment Theme 5: The vitamin market is experiencing supply disruptions, with companies like Zhejiang Medicine and New Hecheng recommended for monitoring [9].